It’s the beginning of 2023 and psychedelics companies are updating the public on their developmental and clinical progress as well as their selected milestones for the year.
Digital Brands Group (NASDAQ:DBGI) reported quarterly losses of $(0.76) per share. This is a 91.44 percent decrease over losses of $(0.40) per share from the same period last year. The company reported $4.00 million in
Illumina Inc (NASDAQ:ILMN) entered a strategic research collaboration with AstraZeneca plc (NASDAQ:AZN) on drug target discovery. Financial and other details of the partnership…